Asuransi Sun Critical Medicare

Critical Illness agency Analysis pending

Critical illness protection product by Sun Life Indonesia.

★ The Insurer’s Play

analytical interpretation

Limited read — analysis pending. Likely intent: sell lump-sum protection against a small set of high-cost diagnoses. Full read pending a Strategic Brief.

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

Fit guidance becomes available once this product has a Strategic Brief.

Key facts

Coverage

Coverage period: up to 100 years (per product card)
Specific SA and terms: not available (dedicated page returning 404)

Premium

Not disclosed; product card shows “Premi terjangkau” (affordable premium)

Target Customer

Not determinable — product page not accessible (HTTP 404).

Key Features

Comprehensive critical illness protection
Affordable premium
Long-term coverage (100 years)

Expert · technical detail

Raw fields

Entity type: conventional
Channel: agency
Category: critical-illness
Benchmark carrier: no
Extraction quality: low
First cataloged: 2026-06-03
Last updated: 2026-06-03

Source documents

No source document URLs on record.

Insurer product page ↗

How Critical Illness products differ

Still building · 77% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.

Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)

Expert · full Strategic Brief

No Strategic Brief yet for this product — analysis pending.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.